• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Geographic Atrophy

Geographic Atrophy - 37 Studies Found

Completed : A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy
: Geographic Atrophy
: 2010-10-25
:
  • Drug: FCFD4514S Repeating intr

Completed : An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima B)
: Geographic Atrophy
: 2015-03-23
: Other: No intervention No intervention administered in this study
Completed : Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
: Geographic Atrophy
: 2016-04-18
: Drug: Lampalizumab Lampalizumab 10 mg will be administered every 4 or 6 weeks according to the frequency
Completed : An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A).
: Geographic Atrophy
: 2015-06-19
: Other: No intervention No intervention administered in this study
Completed : Micropulse Laser for Geographic Atrophy
:
  • Geographic Atrophy
  • Age-related Macular Degeneration

: 2013-02-25
: Procedure: Micropulse Between 1 and 3 sessions of micropulse laser will be applied in the inferior hemir
Completed : Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
:
  • Geographic Atrophy
  • Dry Age Related Macular Degeneration
  • : 2007-01-30
    : Drug: Fenretinide Once daily 30 minutes after the evening meal for 24 months
Terminated : Geographic Atrophy Treatment Evaluation
:
  • Geographic Atrophy
  • Age-Related Macular Degeneration

: 2009-04-27
:
  • Drug: AL-8309B Ophthalmic Solution
  • Drug: A

Completed : Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
: Geographic Atrophy
: 2013-02-28
:
  • Drug: ACU-4429 Take orally onc

Completed : Geographic Atrophy and Intravitreal Ranibizumab Injections
:
  • Age-related Macular Degeneration
  • Geographic Atrophy

: 2015-02-20
: Drug: Ranibizumab The medication Ranibizumab is routine standard of care for patients with wet AMD, and
Recruiting : A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
:
  • Geographic Atrophy
  • Macular Degeneration

: 2016-02-16
:
  • Drug: Zimura®
  • Drug: Sham

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.